Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 28, 2026. Lead counts include only confirmed lead roles.
New companies 9 · Follow-on 0
Stages: Series A 4, Undisclosed 3, Series B 1, Series C+ 1
Footprint $25M Series BKastle $24M Series APie $19.5M Series ANew companies 9 · Follow-on 0
Stages: Series A 4, Seed 2, Undisclosed 2, Pre-seed 1
NUNOS €570K Pre-Seedsyte €9M Series APhagestack Undisclosed NRW.BANK investmentNew companies 8 · Follow-on 1
Stages: Series C+ 8, Undisclosed 1
Crusoe $3.9B Series F (initial close; anticipated total)Positron AI ≤$875M Series C and Series C-1 financing packageGatik $200M Series DNew companies 8 · Follow-on 1
Stages: Seed 3, Series A 3, Series B 1, Series C+ 1, Undisclosed 1
Hang Ten Systems $53M Additional seed fundingDeepCtrls Undisclosed Series B+Emerald AI $150M Series ANew companies 9 · Follow-on 0
Stages: Seed 3, Growth 2, Series B 2, Series A 1, Undisclosed 1
Ferm Labs €3M SeedCircular Materials €11.8M UndisclosedProxima Fusion €411M GrowthNew companies 9 · Follow-on 0
Stages: Seed 4, Series A 3, Pre-seed 1, Undisclosed 1
Resolutiion $10.4M Funding roundMaven Robotics $100M Series Amicroagi $55M SeedNew companies 9 · Follow-on 0
Stages: Seed 5, Series A 3, Series B 1
GenHealth.ai $16.5M Series ADynamic Creatures Undisclosed SeedNebex $30M SeedNew companies 8 · Follow-on 1
Stages: Series C+ 3, Series A 2, Series B 2, Seed 1, Undisclosed 1
Lightfield $47M Series AAntioch $32M Series AUpwind Security ~$300M FundingNew companies 9 · Follow-on 0
Stages: Seed 4, Series A 3, Series B 1, Series C+ 1
Solstice Oncology $225M Series AActualyze AI $7M SeedDraig Therapeutics $65M Series BNew companies 9 · Follow-on 0
Stages: Series C+ 5, Series B 2, Growth 1, Undisclosed 1
Harvey $550M Series HSuniva $835M Debt and equity financingOwner $240M Series DNew companies 8 · Follow-on 1
Stages: Undisclosed 3, Series B 2, Series C+ 2, Growth 1, Seed 1
Lasso Security $30M FundingfileAI Undisclosed StrategicWhale $40M Series CNew companies 8 · Follow-on 1
Stages: Series A 3, Undisclosed 3, Series C+ 2, Series B 1
AusperBio $120M Series CVivacta Biotechnology $50M Series A+Pulnovo Medical $100M StrategicNew companies 9 · Follow-on 0
Stages: Series C+ 6, Undisclosed 2, Series A 1
Cyclic Materials $75M StrategicCastelion $1B Series CK2 Space $500M Series DNew companies 7 · Follow-on 1
Stages: Series A 3, Seed 2, Series B 1, Series C+ 1, Undisclosed 1
General Compute $100M Series ACoherence Neuro $45M Series AHeidi $100M Series CNew companies 8 · Follow-on 0
Stages: Series A 3, Series B 3, Seed 2
Vera Health $28.5M Series AAutopoiesis Sciences $11M SeedBluefish AI $43M Series BNew companies 8 · Follow-on 0
Stages: Series A 5, Seed 1, Series B 1, Series C+ 1
Nevis $70M Series BBiolevate €30M Series ASyntetica $30M Series ANew companies 8 · Follow-on 0
Stages: Series A 3, Seed 2, Series B 2, Undisclosed 1
Coast $35M UndisclosedTown $108M Series BStay >R$30M Series ANew companies 8 · Follow-on 0
Stages: Seed 5, Pre-seed 2, Undisclosed 1
Marrow $2M Pre-seedIMMIX $3.5M UndisclosedCleavr €8M SeedNew companies 8 · Follow-on 0
Stages: Seed 3, Pre-seed 2, Undisclosed 2, Series B 1
Enact Intelligence $30M Pre-seedFlow Engineering $50M Series BMarker $13M SeedNew companies 8 · Follow-on 0
Stages: Series B 3, Series A 2, Series C+ 2, Undisclosed 1
Blackwall $100M Series CWhiteLab Genomics $26M Series BAbstract $25M UndisclosedNew companies 8 · Follow-on 0
Stages: Series C+ 3, Series A 2, Undisclosed 2, Series B 1
Baba $40M Series AAbby Care $82M Series CThyme Care >$125M Series ENew companies 8 · Follow-on 0
Stages: Seed 3, Series B 2, Undisclosed 2, Pre-seed 1
Rebill $5.4M Pre-Series AConway Research Undisclosed First financingTesterArmy €1M Pre-SeedNew companies 8 · Follow-on 0
Stages: Series C+ 4, Undisclosed 2, Series A 1, Series B 1
Tenstorrent $1.5B Series EA5X R$360M Series DHiddenLayer $100M Series BNew companies 8 · Follow-on 0
Stages: Series A 4, Seed 3, Undisclosed 1
XRlabs $8.4M SeedMesa Quantum $11.8M UndisclosedPicoJool $27.5M Series ANew companies 8 · Follow-on 0
Stages: Series A 4, Series C+ 3, Series B 1
OMass Therapeutics $310M Series CSling Therapeutics, Inc. $123M Series CSolstice Oncology $225M Series ANew companies 8 · Follow-on 0
Stages: Series A 2, Series C+ 2, Undisclosed 2, Seed 1, Series B 1
Abby Care $82M Series CBasalt Health $20M Series AThyme Care >$125M Series ENew companies 8 · Follow-on 0
Stages: Series A 3, Series C+ 2, Seed 1, Series B 1, Undisclosed 1
Stand $70M Series CBuywander $21M Series AQueen One $25M Series ANew companies 8 · Follow-on 0
Stages: Series B 3, Series A 2, Seed 1, Series C+ 1, Undisclosed 1
Mueon $65M Series AOdyssey $310M Series BbitBiome >$45M Seed+New companies 8 · Follow-on 0
Stages: Seed 7, Undisclosed 1
Otter Health $8M SeedSnag $4M SeedEllis $10M SeedNew companies 8 · Follow-on 0
Stages: Series B 3, Series C+ 2, Pre-seed 1, Seed 1, Series A 1
Labelbox >$100M Series EKairon Health $5M SeedAssort Health $120M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.